Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Additional Other Comprehensive Income (Loss)
Equity of Non-controlling Interest
Total
Stockholders' equity, Beginning balance at Feb. 01, 2020 $ 82 $ 452,833 $ (434,221)     $ 18,694
Common Stock, Shares, Outstanding period beginning at Feb. 01, 2020 8,208,227          
Net loss     (6,828)     (6,828)
Common stock issuances pursuant to equity compensation awards $ 1 (3)       (2)
Common stock issuances pursuant to equity compensation awards (in shares) 32,652          
Share-based payment compensation   615       615
Common stock and warrant issuance $ 7 1,418       1,425
Common stock and warrant issuance (in shares) 731,937          
Stockholders' equity, ending balance at May. 02, 2020 $ 90 454,863 (441,049)     13,904
Common Stock, Shares, Outstanding period end at May. 02, 2020 8,972,816          
Net loss     1,054     1,054
Common stock issuances pursuant to equity compensation awards $ 1 (6)       (5)
Common stock issuances pursuant to equity compensation awards (in shares) 64,456          
Share-based payment compensation   108       108
Common stock and warrant issuance $ 10 2,375       2,385
Common stock and warrant issuance (in shares) 1,104,377          
Stockholders' equity, ending balance at Aug. 01, 2020 $ 101 457,340 (439,995)     17,446
Common Stock, Shares, Outstanding period end at Aug. 01, 2020 10,141,649          
Net loss     (4,748)     (4,748)
Common stock issuances pursuant to equity compensation awards   (1)       $ (1)
Common stock issuances pursuant to equity compensation awards (in shares) 313          
Exercise of warrants $ 1 (1)        
Exercise of warrants (in shares) 114,698         114,698
Share-based payment compensation   504       $ 504
Common stock and warrant issuance $ 28 15,805       15,833
Common stock and warrant issuance (in shares) 2,760,000          
Stockholders' equity, ending balance at Oct. 31, 2020 $ 130 473,647 (444,743)     29,034
Common Stock, Shares, Outstanding period end at Oct. 31, 2020 13,016,660          
Stockholders' equity, Beginning balance at Jan. 30, 2021 $ 130 474,375 (447,455)     $ 27,050
Common Stock, Shares, Outstanding period beginning at Jan. 30, 2021 13,019,061         13,019,061
Net loss     (3,228)   $ (150) $ (3,378)
Common stock issuances pursuant to equity compensation awards $ 1 (262)       (261)
Common stock issuances pursuant to equity compensation awards (in shares) 76,341          
Share-based payment compensation   668       668
Common stock and warrant issuance $ 33 21,191       21,224
Common stock and warrant issuance (in shares) 3,289,000          
Investment of non-controlling interest         3,430 3,430
Stockholders' equity, ending balance at May. 01, 2021 $ 164 495,972 (450,683)   3,280 48,733
Common Stock, Shares, Outstanding period end at May. 01, 2021 16,384,402          
Stockholders' equity, Beginning balance at Jan. 30, 2021 $ 130 474,375 (447,455)     $ 27,050
Common Stock, Shares, Outstanding period beginning at Jan. 30, 2021 13,019,061         13,019,061
Stockholders' equity, ending balance at Oct. 30, 2021 $ 213 537,987 (464,424) $ (371) 3,148 $ 76,553
Common Stock, Shares, Outstanding period end at Oct. 30, 2021 21,560,514         21,560,514
Stockholders' equity, Beginning balance at May. 01, 2021 $ 164 495,972 (450,683)   3,280 $ 48,733
Common Stock, Shares, Outstanding period beginning at May. 01, 2021 16,384,402          
Net loss     (4,249)   (132) (4,381)
Common stock issuances pursuant to equity compensation awards (in shares) 39,094          
Share-based payment compensation   768       768
Common stock and warrant issuance $ 48 40,095       40,143
Common stock and warrant issuance (in shares) 4,830,918          
Stockholders' equity, ending balance at Jul. 31, 2021 $ 212 536,835 (454,932)   3,148 85,263
Common Stock, Shares, Outstanding period end at Jul. 31, 2021 21,254,414          
Net loss     (9,492)     (9,492)
Common stock issuances pursuant to equity compensation awards $ 1 67       68
Common stock issuances pursuant to equity compensation awards (in shares) 306,100          
Share-based payment compensation   949       949
Common stock and warrant issuance   136       136
Other Comprehensive Income (loss)       (371)   (371)
Stockholders' equity, ending balance at Oct. 30, 2021 $ 213 $ 537,987 $ (464,424) $ (371) $ 3,148 $ 76,553
Common Stock, Shares, Outstanding period end at Oct. 30, 2021 21,560,514         21,560,514